Conversely, inhibition of NF-κB in obese animals by a selective NF-κB inhibitor, celastrol, ameliorates pathophysiological processes such as obesity-induced kidney injury, insulin resistance, and hepatic steatosis [113,114,115]. The gene discussed is NFKB1; the disease is obesity due to melanocortin 4 receptor deficiency.